Xenetic Biosciences, Inc. (XBIO)
Nasdaq: XBIO · Pharmaceutical Preparations · Framingham, MA · filing with the SEC since 2011
Who runs Xenetic Biosciences, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Parslow James F
Interim CEO and CFO. First filing Apr 2017, latest Apr 23, 2026, 0 filings in all.
Officers reporting now
1
of 5 people with a filing in the last fifteen months
Directors reporting now
4
15 people on the record since 2016
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Parslow James F | Interim CEO and CFO | Apr 2017 | Apr 23, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Borisenko Grigory G. | director | Sep 2019 | Jan 5, 2026 | none |
| Dastoor Firdaus J. | director | Nov 2016 | Jan 5, 2026 | none |
| Kornberg Roger D. | director | Nov 2016 | Jan 5, 2026 | none |
| Vinogradov Alexey Andreevich | director | Aug 2019 | Jan 5, 2026 | none |
Earlier names on the record12, newest filing first
Mizrahy Moshe · director · last filing Dec 2023Eisenberg Jeffrey F · officer · last filing Dec 2023Lockshin Curtis · officer · last filing Dec 2023Callaway James Eric · director · last filing Dec 2023Logal Adam · director · last filing Dec 2023Genkin Dmitry · director · last filing Jul 2019LLC Synbio · 10% owner · last filing Oct 2017Pjsc Pharmsynthez · 10% owner · last filing Oct 2017Deptula-Hicks Darlene M · director · last filing Aug 2017Benz Edward J. Jr · director · last filing Aug 2017Maguire Michael Scott · officer · last filing Jun 2017Knyazev Roman · director · last filing Jun 2017
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.